BRAINTEASER Architecture for Integration of AI Models and Interactive Tools for Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) Progression Prediction and Management

The presented platform architecture and deployed implementation in real-life clinical and home care settings on four Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) study sites, integrates the novel working tools for improved disease management with the initial releases of the AI models for disease monitoring. The described robust industry-standard scalable platform is to be a referent example of the integration approach based on loose coupling APIs and industry open standard human-readable and language-independent interface specifications, and its successful baseline implementation for further upcoming releases of additional and more advanced AI models and supporting pipelines (such as for ALS and MS progression prediction, patient stratification, and ambiental exposure modelling) in the following development.